1. Home
  2. ICU vs GNLN Comparison

ICU vs GNLN Comparison

Compare ICU & GNLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICU
  • GNLN
  • Stock Information
  • Founded
  • ICU 2018
  • GNLN 2005
  • Country
  • ICU United States
  • GNLN United States
  • Employees
  • ICU N/A
  • GNLN N/A
  • Industry
  • ICU Biotechnology: Pharmaceutical Preparations
  • GNLN Durable Goods
  • Sector
  • ICU Health Care
  • GNLN Consumer Discretionary
  • Exchange
  • ICU Nasdaq
  • GNLN Nasdaq
  • Market Cap
  • ICU 15.9M
  • GNLN 12.9M
  • IPO Year
  • ICU N/A
  • GNLN 2019
  • Fundamental
  • Price
  • ICU $0.57
  • GNLN $3.18
  • Analyst Decision
  • ICU
  • GNLN
  • Analyst Count
  • ICU 0
  • GNLN 0
  • Target Price
  • ICU N/A
  • GNLN N/A
  • AVG Volume (30 Days)
  • ICU 1.7M
  • GNLN 778.0K
  • Earning Date
  • ICU 11-13-2025
  • GNLN 11-14-2025
  • Dividend Yield
  • ICU N/A
  • GNLN N/A
  • EPS Growth
  • ICU N/A
  • GNLN N/A
  • EPS
  • ICU N/A
  • GNLN N/A
  • Revenue
  • ICU $766,000.00
  • GNLN $7,954,000.00
  • Revenue This Year
  • ICU $820.00
  • GNLN $1,541.21
  • Revenue Next Year
  • ICU $63.37
  • GNLN N/A
  • P/E Ratio
  • ICU N/A
  • GNLN N/A
  • Revenue Growth
  • ICU N/A
  • GNLN N/A
  • 52 Week Low
  • ICU $0.31
  • GNLN $2.75
  • 52 Week High
  • ICU $3.57
  • GNLN $2,985.00
  • Technical
  • Relative Strength Index (RSI)
  • ICU 39.98
  • GNLN 40.17
  • Support Level
  • ICU $0.60
  • GNLN $3.16
  • Resistance Level
  • ICU $0.65
  • GNLN $3.41
  • Average True Range (ATR)
  • ICU 0.05
  • GNLN 0.38
  • MACD
  • ICU 0.00
  • GNLN -0.09
  • Stochastic Oscillator
  • ICU 26.62
  • GNLN 24.16

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

About GNLN Greenlane Holdings Inc.

Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.

Share on Social Networks: